Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 6, 2004, Pages 809-812

  Itoh, Tatsuya ^a   Itagaki, Shirou ^b   Sasaki, Kentaro ^b   Hirano, Takeshi ^b   Takemoto, Isao ^a   Iseki, Ken ^b  

^a Sapporo Social Insurance General Hospital   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 ETHYL 10 HYDROXYCAMPTOTHECIN GLUCURONIDE; BROMSULFOPHTHALEIN; DRUG METABOLITE; HANGE SHASHIN TO; IRINOTECAN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BILE; BILIARY EXCRETION; BLOOD SAMPLING; BOLUS INJECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; FEMORAL VEIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS CATHETER; MALE; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; BILE; CAMPTOTHECIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCURONIDES; MALE; RATS; RATS, WISTAR; SULFOBROMOPHTHALEIN;

EID: 3042641999     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023420     Document Type: Article

References (14)

1. Abigerges, D., Armand, J. P., Chabot, G. G., Da Costa, L., Fadel, E., Cote, C., Herait, P., Gandia, D. (1994) Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J. Natl. Cancer Inst. 86: 446-449
2. Atsumi, R., Suzuki, W., Hakusui, H. (1991) Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion. Xenobiotica 21: 1159-1169
3. Gupta, E., Safa, A. R., Wang, X., Ratain, M. J. (1996) Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A. Cancer Res. 56: 1309-1314
4. Houghton, P. J., Cheshire, P. J., Hallman, J. C., Bissery, M. C., Mathieru-Boue, A., Houghton, J. A. (1993) Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin. Cancer Res. 53: 2823-2829
5. Itagaki, S., Sugawara, M., Kobayashi, M., Miyazaki, K., Iseki, K. (2003) Mechanism of active secretion of phenolsulfonphthalein in the liver via MRP2 (abcc2), an organic anion transporter. Drug Metab. Pharmacokinet. 18: 238-244
6. Itoh, T., Takemoto, I., Hata, Y., Takaoka, K., Sugawara, M., Iseki, K., Miyazaki, K. (2000) Determination of the lactone forms and carboxylate forms of irinotecan and its active metabolite, glucuronide by high-performance liquid chromatography. Jpn. J. Ther. Drug Monit. 17: 383-389
7. Itoh, T., Takemoto, I., Itagaki, S., Sasaki, K., Hirano, T., Iseki, K. (2004) Biliary excretion of irinotecan and its metabolites. J. Pharm. Pharmaceut. Sci. 7: 13-18
8. Kaneda, N., Yokokura, T. (1990) Nonlinear pharmacokinetics of CPT-11 in rats. Cancer Res. 50: 1721-1725
9. Kehrer, D. F. S., Sparreboom, A., Verweij, J., Debrujn, P., Nierop, C. A., Van de Schraaf, J., Ruijgrok, E. J., De Jonge, M. J. A. (2001) Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. Clin. Cancer Res. 7: 1136-1141
10. Rivory, L. P., Bowles, M. R., Robert, J., Pond, S. M. (1996) Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. Biochem. Pharmacol. 52: 1103-1111
11. Takasuna, K., Kasai, Y., Kitano, Y., Mori, K., Kobayashi, R., Hagiwara, T., Kakihata, K., Hirohashi, M., Nomura, M., Nagai, E., Kamataki, T. (1995) Prospective effect of Kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Jpn. J. Cancer Res. 86: 978-984
12. Takasuna, K., Hagiwara, T., Hirohashi, M., Nomura, M., Nagai, E., Yokoiu, T., Kamataki, T. (1996) Involvement of b-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res. 56: 3752-3757
13. van Groeningen, C. J., Van der Vijgh, W. J., Baars, J. J., Stieltjes, H., Huibregtse, K., Pinedo, H. M. (2000) Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: a need for guidelines. Clin. Cancer Res. 6: 1342-1346
14. Winkler, K. (1961) Urinary elimination of bromsulfalein in man. Scand. J. Clin. Lab. Invest. 13: 44-49